NO175134C - Fremgangsmåte for fremstilling av et frysetörket injeksjonspreparat av (7S,9S)-9-acetyl-9-amino-7-[(2-deoksy- tro-pentopyranosyl)oksyÅ-7,8,9,10-tetrahydro-6,11-dihydroksy-naftacen-5,12-dion eller salter derav - Google Patents

Fremgangsmåte for fremstilling av et frysetörket injeksjonspreparat av (7S,9S)-9-acetyl-9-amino-7-[(2-deoksy- tro-pentopyranosyl)oksyÅ-7,8,9,10-tetrahydro-6,11-dihydroksy-naftacen-5,12-dion eller salter derav

Info

Publication number
NO175134C
NO175134C NO883447A NO883447A NO175134C NO 175134 C NO175134 C NO 175134C NO 883447 A NO883447 A NO 883447A NO 883447 A NO883447 A NO 883447A NO 175134 C NO175134 C NO 175134C
Authority
NO
Norway
Prior art keywords
preparation
salts
pentopyranosyl
naphthacene
dione
Prior art date
Application number
NO883447A
Other languages
English (en)
Norwegian (no)
Other versions
NO175134B (no
NO883447D0 (no
NO883447L (no
Inventor
Yasuhisa Sakamaki
Yukio Ozaki
Norihiko Tanno
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Publication of NO883447D0 publication Critical patent/NO883447D0/no
Publication of NO883447L publication Critical patent/NO883447L/no
Publication of NO175134B publication Critical patent/NO175134B/no
Publication of NO175134C publication Critical patent/NO175134C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO883447A 1987-08-05 1988-08-03 Fremgangsmåte for fremstilling av et frysetörket injeksjonspreparat av (7S,9S)-9-acetyl-9-amino-7-[(2-deoksy- tro-pentopyranosyl)oksyÅ-7,8,9,10-tetrahydro-6,11-dihydroksy-naftacen-5,12-dion eller salter derav NO175134C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62197032A JP2603480B2 (ja) 1987-08-05 1987-08-05 安定化されたアンスラサイクリン系製剤

Publications (4)

Publication Number Publication Date
NO883447D0 NO883447D0 (no) 1988-08-03
NO883447L NO883447L (no) 1989-02-06
NO175134B NO175134B (no) 1994-05-30
NO175134C true NO175134C (no) 1994-09-07

Family

ID=16367605

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883447A NO175134C (no) 1987-08-05 1988-08-03 Fremgangsmåte for fremstilling av et frysetörket injeksjonspreparat av (7S,9S)-9-acetyl-9-amino-7-[(2-deoksy- tro-pentopyranosyl)oksyÅ-7,8,9,10-tetrahydro-6,11-dihydroksy-naftacen-5,12-dion eller salter derav

Country Status (14)

Country Link
US (1) US4952566A (da)
EP (1) EP0302729B1 (da)
JP (1) JP2603480B2 (da)
KR (1) KR970000507B1 (da)
AT (1) ATE71526T1 (da)
AU (1) AU609168B2 (da)
CA (1) CA1324959C (da)
DE (1) DE3867751D1 (da)
DK (1) DK173317B1 (da)
ES (1) ES2038763T3 (da)
FI (1) FI91483C (da)
GR (1) GR3004330T3 (da)
NO (1) NO175134C (da)
NZ (1) NZ225654A (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222489B1 (hu) * 1990-07-25 2003-07-28 Novartis Ag. Stabilizált gyógyszerkészítmények és eljárás az előállításukra
US6300362B1 (en) 1990-07-25 2001-10-09 Novartis Ag (Formerly Sandoz Ltd.) Stabilized pharmaceutical compositions comprising acid donors
FR2665834B1 (fr) * 1991-07-24 2001-02-23 Sandoz Sa Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique, et sa preparation.
DE19741715A1 (de) * 1997-09-22 1999-03-25 Hoechst Ag Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
ATE315571T1 (de) * 1997-11-28 2006-02-15 Dainippon Sumitomo Pharma Co Kristallines amrubicin-hydrochlorid
KR100932407B1 (ko) * 2001-10-23 2009-12-17 다이닛본 스미토모 세이야꾸 가부시끼가이샤 염산 암루비신의 안정화
JP4594736B2 (ja) * 2002-11-29 2010-12-08 大日本住友製薬株式会社 安定化されたアンスラサイクリン系化合物の凍結乾燥製剤
CN100395255C (zh) * 2005-02-02 2008-06-18 江苏豪森药业股份有限公司 马来酸氨柔比星盐及其制备方法和用途
BRPI0605832A2 (pt) * 2005-05-11 2009-05-26 Sicor Inc glicosìdeos de antraciclina liofilizados estáveis
JP5389910B2 (ja) * 2009-05-27 2014-01-15 大日本住友製薬株式会社 アンスラサイクリン系化合物の安定な凍結乾燥製剤
AU2013364204B2 (en) * 2012-12-19 2016-03-03 Colgate-Palmolive Company Two component compositions containing zinc amino acid halide complexes and cysteine
WO2016024369A1 (ja) * 2014-08-13 2016-02-18 テバ製薬株式会社 がん治療用医薬組成物
WO2019094819A2 (en) * 2017-11-09 2019-05-16 Abon Pharmaceuticals, Llc Intravenous delivery systems for chemotherapy drugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2522187C2 (de) * 1975-05-17 1977-10-28 Byk Gulden Lomberg Chem Fab Verwendung von Cystein oder dessen Säureadditionssalz und Natriumdisulfit zur Stabilisierung von injizierbaren, einen pH-Wert zwischen 7 und 9 aufweisenden, Vitamin B tief 12 und nichtsteroidal Entzündungshemmer enthaltenden Arzneimitteln
US4540695A (en) * 1981-08-12 1985-09-10 Sumitomo Chemical Co., Ltd. Aminonaphthacene derivatives and their use
JPS5976099A (ja) * 1982-10-22 1984-04-28 Sumitomo Chem Co Ltd アミノナフタセン誘導体とその製造方法
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions

Also Published As

Publication number Publication date
ATE71526T1 (de) 1992-02-15
FI883602A (fi) 1989-02-06
JPS6440493A (en) 1989-02-10
JP2603480B2 (ja) 1997-04-23
AU609168B2 (en) 1991-04-26
NO175134B (no) 1994-05-30
AU2042188A (en) 1989-02-09
GR3004330T3 (da) 1993-03-31
FI883602A0 (fi) 1988-08-01
FI91483C (fi) 1994-07-11
NO883447D0 (no) 1988-08-03
EP0302729B1 (en) 1992-01-15
DE3867751D1 (de) 1992-02-27
NZ225654A (en) 1991-03-26
DK436688A (da) 1989-02-06
EP0302729A1 (en) 1989-02-08
DK436688D0 (da) 1988-08-04
CA1324959C (en) 1993-12-07
NO883447L (no) 1989-02-06
FI91483B (fi) 1994-03-31
DK173317B1 (da) 2000-07-17
KR890003791A (ko) 1989-04-18
ES2038763T3 (es) 1993-08-01
KR970000507B1 (ko) 1997-01-13
US4952566A (en) 1990-08-28

Similar Documents

Publication Publication Date Title
NO175134C (no) Fremgangsmåte for fremstilling av et frysetörket injeksjonspreparat av (7S,9S)-9-acetyl-9-amino-7-[(2-deoksy- tro-pentopyranosyl)oksyÅ-7,8,9,10-tetrahydro-6,11-dihydroksy-naftacen-5,12-dion eller salter derav
FR2629819B1 (fr) Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
PT88448A (pt) Process for preparing antiprotozoal pharmaceutical compositionscontaining azithromycin or a derivative thereof
NO941726D0 (no) Fremgangsmåte for fremstilling av 4-amino-1-hydroxy-butyliden-1,2-bisfosfonsyre
FR2629818B1 (fr) Procede de preparation du taxol
DK0382173T3 (da) Substans PF 1022, fremgangsmåde til fremstilling heraf og anthelmintisk præparat indeholdende denne
PT81656B (pt) Processo para a preparacao de polissacarideos bacterianos neutros covalentemente modificados, e de conjugados covalentes estaveis desses polissacarideos e de proteinas imunogenicas
FI890068A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2-bis(aminometyyli)syklobutaani-platinakompleksien valmistamiseksi
DE69002817D1 (de) Vakzine.
SE441598B (sv) Forfarande for framstellning av 16-ledade makrolida antibiotika och syraadditionssalter derav, omfattande nya derivat av tylosin, angolamycin och spiramycin
PT92016A (pt) Processo de preparacao de 3-furaldeidos substituidos na posicao 5
SE8008181L (sv) Linkomycin och clindamycinanaloger
FI945626A (fi) Menetelmä 2,2-difluoriketeenisilyyliasetaalien ja alfa, alfa-difluori-beta-silyylioksi-1,3-dioksolaani-4-propaanihappoestereiden valmistamiseksi
DE69025505D1 (de) Tylosin-Derivate
EP0254369A3 (en) Branched polycarbonates containing aliphatic policarboxylic acids or derivatives thereof, and process for their preparation
DE3880088D1 (de) Ethylierte avermectine.
ES2059882T3 (es) Preparacion de la sustancia fr 115224 para administracion parenteral.
DE68911067D1 (de) Platin-(II)-diamin-Komplex, Verfahren zur Herstellung dieser Verbindung, Zusammensetzung mit Antitumorwirkung, die mindestens eine Platin-Verbindung enthält, und geformte Zusammensetzung mit Antitumorwirkung.
ES2080719T3 (es) El operon gal de streptomyces.
ES2036602T3 (es) Un procedimiento de preparacion de 4'-desoxi-13(s)-dihidro-4'-yododoxorubicina.
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
ES2053697T3 (es) Dactilociclina a y dactilociclina b.

Legal Events

Date Code Title Description
MK1K Patent expired